KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Short term Debt (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Short term Debt for 7 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Short term Debt changed 0.0% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $5.0 million for FY2025, 0.0% changed from the prior year.
  • Short term Debt hit $5.0 million in Q4 2025 for GoodRx Holdings, roughly flat from $5.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $8.8 million in Q4 2023 to a low of $3.8 million in Q3 2024.
  • Historically, Short term Debt has averaged $6.4 million across 5 years, with a median of $7.0 million in 2021.
  • Biggest five-year swings in Short term Debt: crashed 46.65% in 2024 and later soared 33.33% in 2025.
  • Year by year, Short term Debt stood at $7.0 million in 2021, then changed by 0.0% to $7.0 million in 2022, then rose by 25.01% to $8.8 million in 2023, then plummeted by 43.1% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
  • Business Quant data shows Short term Debt for GDRX at $5.0 million in Q4 2025, $5.0 million in Q3 2025, and $5.0 million in Q2 2025.